MCM
ANGO icon

MAI Capital Management’s AngioDynamics ANGO Stock Holding History

MAI Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-103
Closed -$1.17K – 2218
2026
Q1 		$1.17K Buy
103
+68
+194% +$737 ﹤0.01% 4124
2025
Q4 		$450 Buy
+35
New +$432 ﹤0.01% 3861

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MAI Capital Management's ANGO Position: Q2 2026 in Review

MAI Capital Management sold out of AngioDynamics (ANGO) in Q2 2026, closing a stake of 103 shares — an estimated $1.17K sold.

MAI Capital Management first reported a position in ANGO in Q4 2025 and held it in 2 quarters. The position peaked at $1.17K in Q1 2026. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • MAI Capital Management reported no remaining AngioDynamics position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 103 AngioDynamics shares in Q2 2026, an estimated $1.17K.
  • MAI Capital Management first reported a position in AngioDynamics in Q4 2025 and held it in 2 quarters.
  • MAI Capital Management's AngioDynamics position peaked at $1.17K in Q1 2026.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.